Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLMePsA Study
NCT04108468Phase 3Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Oct 2015
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in psoriatic arthritis (PsA), sponsored by Leeds Teaching Hospitals NHS Trust. Started Oct 2015; status: completed.
02
Drugs
golimumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT04108468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04108468.